Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
5
×
life sciences
national blog main
san diego blog main
san diego top stories
boston blog main
boston top stories
clinical trials
fda
national top stories
new york blog main
new york top stories
proteon therapeutics
san francisco blog main
san francisco top stories
startups
tc
3b pharmaceuticals
abeona therapeutics
acetylon pharmaceuticals
acute myeloid leukemia
adicet bio
aegerion pharmaceuticals
akcea therapeutics
alkermes
allan kaspar
altria
ambys medicines
amgen
amphivena therapeutics
amryt pharma
andrew komjathy
antimicrobial
aron knickerbocker
artara therapeutics
articles
artificial intelligence
avexis
bial
bio
What
control
5
×
disease
according
biotech
called
centers
startup
add
aiming
akcea
ambys
antibiotic
bci
big
biohacker
brain
bugs
carbidopa
cases
cdc
cigarettes
combination
company
daily
deadly
deal
deaths
debuted
direct
diseases
drugs
electronic
elon
endeavors
experience
fda
formed
founded
future
gets
Language
unset
Current search:
control
×
biotech
×
@xconomy.com
3 years ago
Neurocrine Gets FDA Nod for Once-Daily “Add-On” Parkinson’s Pill
@xconomy.com
4 years ago
Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More
@techcrunch.com
4 years ago
How to watch Elon Musk’s Neuralink brain control interface startup presentation live
@techcrunch.com
5 years ago
HP is ‘printing’ drugs for the CDC to speed up antibiotic testing
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?